Medicinova Inc [NASDAQ: MNOV] jumped around 0.01 points on Thursday, while shares priced at $1.19 at the close of the session, up 0.85%.
Medicinova Inc stock is now -26.77% down from its year-to-date (YTD) trading value. MNOV Stock saw the intraday high of $1.19 and lowest of $1.168 per share. The company’s 52-week high price is 2.55, which means current price is +5.31% above from all time high which was touched on 01/06/25.
Compared to the average trading volume of 38.91K shares, MNOV reached a trading volume of 38956 in the most recent trading day, which is why market watchdogs consider the stock to be active.
What do top market gurus say about Medicinova Inc [MNOV]?
Based on careful and fact-backed analyses by Wall Street experts, the current consensus on the target price for MNOV shares is $9.00 per share. Analysis on target price and performance of stocks is usually carefully studied by market experts, and the current Wall Street consensus on MNOV stock is a recommendation set at 1.00. This rating represents a strong Buy recommendation, on the scale from 1 to 5, where 5 would mean strong sell, 4 represents Sell, 3 is Hold, and 2 indicates Buy.
Maxim Group have made an estimate for Medicinova Inc shares, keeping their opinion on the stock as Buy, with their previous recommendation back on March 10, 2021. While these analysts kept the previous recommendation, B. Riley FBR raised their target price to Buy. The new note on the price target was released on March 25, 2019, representing the official price target for Medicinova Inc stock. Previously, the target price had yet another raise to $22, while B. Riley FBR Inc. analysts kept a Buy rating on MNOV stock.
The Price to Book ratio for the last quarter was 1.25, with the Price to Cash per share for the same quarter was set at 0.70.
How has MNOV stock performed recently?
Medicinova Inc [MNOV] fell into the red zone at the end of the last week, falling into a negative trend and dropping by -2.46. With this latest performance, MNOV shares dropped by -4.80% in over the last four-week period, additionally sinking by -19.05% over the last 6 months – not to mention a drop of -43.33% in the past year of trading.
Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for MNOV stock in for the last two-week period is set at 39.67, with the RSI for the last a single of trading hit 0.0293, and the three-weeks RSI is set at 0.0347 for Medicinova Inc [MNOV]. The present Moving Average for the last 50 days of trading for this stock 1.2597, while it was recorded at 1.2030 for the last single week of trading, and 1.4321 for the last 200 days.
Medicinova Inc [MNOV]: Deeper insight into the fundamentals
Operating Margin for any stock indicates how profitable investing would be, and Medicinova Inc [MNOV] shares currently have an operating margin of -9883.02% and a Gross Margin at -1.74%. Medicinova Inc’s Net Margin is presently recorded at -8775.80%.
Medicinova Inc (MNOV) Capital Structure & Debt Analysis
According to recent financial data for Medicinova Inc. ( MNOV), the Return on Equity (ROE) stands at -22.66%, highlighting a negative impact on investor capital. The Return on Assets (ROA) is -21.43%, reflecting the company’s efficiency in generating profits from its assets. Additionally, Medicinova Inc’s Return on Invested Capital (ROIC) is -25.15%, showcasing its effectiveness in deploying capital for earnings.
Medicinova Inc (MNOV) Efficiency & Liquidity Metrics
Based on Medicinova Inc’s (MNOV) latest financial statements, the Debt-to-Equity Ratio is 0.01%, indicating its reliance on debt financing relative to shareholder equity.
Medicinova Inc (MNOV) Efficiency & Liquidity Metrics
From an operational efficiency perspective, Medicinova Inc. (MNOV) effectively leverages its workforce, generating an average of -$908461.54 per employee. The company’s liquidity position is robust, with a Current Ratio of 13.26% and a Quick Ratio of 13.26%, indicating strong ability to cover short-term liabilities.
Earnings analysis for Medicinova Inc [MNOV]
With the latest financial reports released by the company, Medicinova Inc posted -0.06/share EPS, while the average EPS was predicted by analysts to be reported at -0.06/share. The progress of the company may be observed through the prism of EPS growth rate, while Wall Street analysts are focusing on predicting the 5-year EPS growth rate for MNOV. When it comes to the mentioned value, analysts are expecting to see the 5-year EPS growth rate for Medicinova Inc go to -20.26%.
Insider trade positions for Medicinova Inc [MNOV]
There are presently around $21.82%, or 22.49%% of MNOV stock, in the hands of institutional investors. The top three institutional holders of MNOV stocks are: ESSEX WOODLANDS MANAGEMENT, INC. with ownership of 1.11 million shares, which is approximately 2.2549%. BLACKROCK INC., holding 0.69 million shares of the stock with an approximate value of $$1.0 million in MNOV stocks shares; and BLACKROCK INC., currently with $$0.9 million in MNOV stock with ownership which is approximately 1.2709%.
